The effect of granulocyte-colony stimulating factor, decitabine, and busulfan-cyclophosphamide versus busulfan-cyclophosphamide conditioning on relapse in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised, phase 3 trial
HematologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- The Lancet. Haematology
- Publicado em
- 23 jan 2023
- Citações
- 23
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
The effect of granulocyte-colony stimulating factor, decitabine, and busulfan-cyclophosphamide versus busulfan-cyclophosphamide conditioning on relapse in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia evolving from myelodysplastic syndrome undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised, phase 3 trial
Li Xuan, Min Dai, Erlie Jiang, Yu Wang, Fen Huang, Zhiping Fan, Na Xu, Danian Nie, Xinquan Liang, Hong Chen et al.
Descritores MeSH
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
- Hematopoietic Stem Cell Transplantation
- Anemia, Refractory, with Excess of Blasts
- Female
- Humans
- Male
- Recurrence
- Granulocyte Colony-Stimulating Factor
- Decitabine